• Research

    Mayo Clinic first in U.S. to test stem cell use in clinical trial for pediatric congenital heart disease

Mayo Clinic recently announced the first stem cell-based clinical trial for congenital heart disease. The clinical trial aims to determine how stem cells derived from autologous umbilical cord blood can help children with Hypoplastic Left Heart Syndrome, a rare defect where the left side of the heart is critically underdeveloped.

Read the full news release and watch a video describing the research: